Literature DB >> 8133089

Persistent cytomegalovirus infection of semen increases risk of AIDS.

R Detels1, C T Leach, K Hennessey, Z Liu, B R Visscher, J D Cherry, J V Giorgi.   

Abstract

To evaluate if persistent cytomegalovirus (CMV) infection of semen in human immunodeficiency virus type 1 (HIV-1) antibody-positive men increases AIDS risk, serial cultures for CMV every 3-6 months were attempted four or more times from 164 men followed 3 years. CMV was never isolated from 58 men, in 1 or 2 samples from 54 (intermittently positive), and in > or = 3 samples from 52 (persistently positive). The Cox model was used to estimate relative hazards while controlling for CD4 cell number. The relative hazard was 2.9 for those intermittently and 4.0 for those persistently positive (P < .001). No Kaposi's sarcoma occurred in culture-negative men, 3 cases (5.6%) in intermittently positive men, and 4 cases (7.7%) in persistently positive men (P < .04). Persistent CMV in semen increases the hazard of AIDS in HIV-1 antibody-positive men, possibly by activating CD4 cells to produce HIV-1. Thus, control of CMV in HIV-1-infected persons may slow progression to AIDS.

Entities:  

Mesh:

Year:  1994        PMID: 8133089     DOI: 10.1093/infdis/169.4.766

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

Review 1.  Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection.

Authors:  Michael L Freeman; Michael M Lederman; Sara Gianella
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

Review 2.  The Sordid Affair Between Human Herpesvirus and HIV.

Authors:  Sara Gianella; Marta Massanella; Joel O Wertheim; Davey M Smith
Journal:  J Infect Dis       Date:  2015-03-06       Impact factor: 5.226

3.  A common anti-cytomegalovirus drug, ganciclovir, inhibits HIV-1 replication in human tissues ex vivo.

Authors:  Christophe Vanpouille; Jean A Bernatchez; Andrea Lisco; Anush Arakelyan; Elisa Saba; Matthias Götte; Leonid Margolis
Journal:  AIDS       Date:  2017-07-17       Impact factor: 4.177

4.  Cytomegalovirus (CMV) DNA load is an independent predictor of CMV disease and survival in advanced AIDS.

Authors:  S A Spector; K Hsia; M Crager; M Pilcher; S Cabral; M J Stempien
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

5.  Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients.

Authors:  S A Spector; R Wong; K Hsia; M Pilcher; M J Stempien
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

6.  Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy.

Authors:  Peter W Hunt; Jeffrey N Martin; Elizabeth Sinclair; Lorrie Epling; Juli Teague; Mark A Jacobson; Russell P Tracy; Lawrence Corey; Steven G Deeks
Journal:  J Infect Dis       Date:  2011-05-15       Impact factor: 5.226

Review 7.  Viruses in the mammalian male genital tract and their effects on the reproductive system.

Authors:  N Dejucq; B Jégou
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

Review 8.  Cytomegalovirus and HIV: A Dangerous Pas de Deux.

Authors:  Sara Gianella; Scott Letendre
Journal:  J Infect Dis       Date:  2016-10-01       Impact factor: 5.226

9.  HIV type 1 and cytomegalovirus coinfection in the female genital tract.

Authors:  Nell S Lurain; Emmanuel S Robert; Jiahong Xu; Margaret Camarca; Alan Landay; Andrea A Kovacs; Patricia S Reichelderfer
Journal:  J Infect Dis       Date:  2004-06-30       Impact factor: 5.226

10.  Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease.

Authors:  David M Naeger; Jeffrey N Martin; Elizabeth Sinclair; Peter W Hunt; David R Bangsberg; Frederick Hecht; Priscilla Hsue; Joseph M McCune; Steven G Deeks
Journal:  PLoS One       Date:  2010-01-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.